New diagnostics company from Berlin

17-Nov-2010 - Germany

Astra Biotech GmbH is a new company whose core focus is the development of diagnostics for the identification of an individual’s predisposition to disease. With this in mind, Astra Biotech GmbH have produced a significant portfolio of assays in areas such as allergies, genetically associated disorders, hormonal dysfunctions, and others.

Key targets so far are for osteoporosis, a condition which affects over 75 million people worldwide and thrombosis, a major fatal disease in developed countries. Other diagnostic kits include one for the determination of an individual’s susceptibility or resistance to oral anticoagulants as well as niche diseases.

Other products include a wide range of convenient ELISA assays offering exceptional value for money to small or medium sized laboratories. A particular focus of Astra Biotech’s ELISA assays are the fertility range along with pre- and neonatal test kits. Soon to be released will be Astra Biotech’s Educator Series – a range of assays specifically for the teaching of analytical procedures without the usual high costs associated with such techniques.

Alexandra Ghica-Cantacuzino, head of International Sales & Marketing at Astra Biotech GmbH says, “Our contribution is to optimise patient healthcare by early diagnosis of potential risks to individuals though innovative assays. In Astra Biotech we believe laboratories must understand patient needs and be more specific in their approach to the identification of risk factors so that early intervention helps to minimise any long term effects of a disease. Our target is to continue to assist clinicians, doctors, hospital staff and medical oriented laboratories to improve overall healthcare standards“.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures
View topic world

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures